b-Included an extraordinary credit of $ 752,000, or 13 cents a share, relating to the purchase and retirement of a portion of the company's convertible subordinated debentures.The company said that net income in 1992 was negatively affected by 5 cents a share relating to the combined effects of the Phar-Mor bankruptcy and the writeoff of costs associated with a November 1991 public stock offering which was subsequently withdrawn. Net income in the fourth quarter of fiscal 1992 was negatively affected by 2 cents a share relating to the Phar-Mor bankruptcy.The company is listed on the Nasdaq National Market System.